Burbach, B. J., O’Flanagan, S. D., Shao, Q., Young, K. M., Slaughter, J. R., Rollins, M. R., . . . Shimizu, Y. (2021). Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. Nature Portfolio.
Chicago Style (17th ed.) CitationBurbach, Brandon J., et al. Irreversible Electroporation Augments Checkpoint Immunotherapy in Prostate Cancer and Promotes Tumor Antigen-specific Tissue-resident Memory CD8+ T Cells. Nature Portfolio, 2021.
MLA (8th ed.) CitationBurbach, Brandon J., et al. Irreversible Electroporation Augments Checkpoint Immunotherapy in Prostate Cancer and Promotes Tumor Antigen-specific Tissue-resident Memory CD8+ T Cells. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.